BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Sarcomas

1. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]